Alcobra Overview

  • Founded
  • 2008
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 27
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 3
  • Investments
  • 1

Alcobra General Information

Description

Developer of a proprietary drug for disabled care patients intended to become a leading global player in the pharmaceutical industry through disruptive efficiency and innovation. The company's pharmaceutical operations are focused on the development of new medications to help patients with cognitive disorders including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • Azrieli Triangle Building
  • 39th Floor 132 Derech Menachem Begin
  • Tel Aviv 6701101
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Alcobra Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Alcobra‘s full profile, request access.

Request a free trial

Alcobra Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a proprietary drug for disabled care patients intended to become a leading global player in the pharmaceuti
Pharmaceuticals
Tel Aviv, Israel
27 As of 2016
0000
00.00 0000-00-00
000000&0 0000

00000000

ommodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fu
000000000000000
Valby, Denmark
0000 As of 0000
00000000

00000000

trud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
0000 000000000
Carmel, IN
0 As of 0000
00.000
000000 0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alcobra Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lundbeck Corporation Valby, Denmark 0000 00000000
0000000000 0000000 Venture Capital-Backed Carmel, IN 0 00.000 000000 0
0000000 0000000000 Formerly VC-backed PA 00 00000 00000000 00000
00000 000000000000 Private Equity-Backed Aberdeen, United Kingdom 00000 000000000000 00000
00000000 Venture Capital-Backed Baltimore, MD 0 00.00 0000000000 00.00
You’re viewing 5 of 16 competitors. Get the full list »

Alcobra Executive Team (6)

Name Title Board Seat Contact Info
Dalia Megiddo Co-Founder
Udi Gilboa Co-Founder
Yaron Daniely Ph.D Chairman
You’re viewing 3 of 6 executive team members. Get the full list »

Alcobra Board Members (1)

Name Representing Role Since
00000 0000000 00.0 Self Chairman 000 0000
To view Alcobra’s complete board members history, request access »

Alcobra Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alcobra Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Alcobra‘s full profile, request access.

Request a free trial

Alcobra Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 16-Nov-2017 0000000 000000 Drug Discovery
To view Alcobra’s complete acquisitions history, request access »